Related references
Note: Only part of the references are listed.Monoclonal Antibodies in the Treatment of Metastatic Colorectal Cancer: A Review
Jolien Tol et al.
CLINICAL THERAPEUTICS (2010)
Myristoylation and Membrane Binding Regulate c-Src Stability and Kinase Activity
Parag Patwardhan et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
The chemical toolbox for monitoring protein fatty acylation and prenylation
Ami N. Hannoush et al.
NATURE CHEMICAL BIOLOGY (2010)
Evolving Treatment of Advanced Colon Cancer
Neil H. Segal et al.
ANNUAL REVIEW OF MEDICINE (2009)
Systemic treatment of colorectal cancer
Brian M. Wolpin et al.
GASTROENTEROLOGY (2008)
N-myristoyltransferase: A potential novel diagnostic marker for colon cancer
Anuraag Shrivastav et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
Adjuvant treatment of colorectal cancer
Brian M. Wolpin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis
CE Ducker et al.
MOLECULAR CANCER RESEARCH (2005)
Epidermal growth factor receptor, c-MET, β-catenin, and p53 expression as prognostic indicators in stage II colon cancer:: A tissue microarray study
MB Resnick et al.
CLINICAL CANCER RESEARCH (2004)
The on-off story of protein palmitoylation
MJ Bijlmakers et al.
TRENDS IN CELL BIOLOGY (2003)
The biology and enzymology of protein N-myristoylation
TA Farazi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Expression of N-myristoyltransferase inhibitor protein and its relationship to c-Src levels in human colon cancer cell lines
RVS Rajala et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)